Quadrant Future Tek Regulatory Approval

Financial Results

Quadrant Future Tek Q2 FY27 Results: Net Loss of ₹7.7 Cr, Loss Narrows

Quadrant Future Tek Ltd reported revenue from operations of ₹37.2 Cr (+8.1% YoY) and a net loss of ₹7.7 Cr for Q2 FY27.

Key figure

Net loss ₹7.7 Cr

Board Meeting Date

Quadrant Future Tek Board Meeting Date

Quadrant Future Tek Ltd scheduled a board meeting on November 10, 2026 to consider Q2 and half-year unaudited results. Trading window stays closed until 48 hours post-announcement.

Other Announcement

Quadrant Future Tek Other Announcement

Quadrant Future Tek Ltd has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI regulations.

Annual General Meeting

Quadrant Future Tek Annual General Meeting

Quadrant Future Tek Limited conducted its 11th Annual General Meeting on September 25, 2026. Shareholders approved the adoption of audited financial statements and director re-appointments.

Other Announcement

Quadrant Future Tek Other Announcement

Quadrant Future Tek Limited informed the exchange about dispatching letters to shareholders, providing web links to access the 11th AGM notice and FY 2025-26 Annual Report.

Annual Report

Quadrant Future Tek Annual Report

Quadrant Future Tek Limited has released its Annual Report for the financial year 2025-26. The report includes corporate overview, statutory reports, and audited financial statements.

Regulatory ApprovalSandur Manganese & Iron Ores Ltd SANDUMAAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Sandur Manganese & Iron Ores Regulatory Approval

Sandur Manganese received environmental clearance to raise iron ore capacity to 9.42 MTPA. No rupee value is disclosed in the filing.

iron ore RoM capacity

9.42 MTPA

Regulatory ApprovalNeogen Chemicals Ltd NEOGENAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Neogen Chemicals Regulatory Approval

Neogen Chemicals received GPCB's revocation of its Dahej plant direction and a CC&A amendment for manufacturing. The revocation is for three months with conditions attached.

Regulatory ApprovalArihant Capital Markets Ltd ARIHANTCAPAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Arihant Capital Markets Regulatory Approval

Arihant Capital Markets received SEBI in-principle approval to sponsor and set up a mutual fund. Final registration remains subject to SEBI's conditions.

Regulatory ApprovalDr. Reddy's Laboratories Ltd DRREDDYAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Dr. Reddy's Laboratories Regulatory Approval

Dr. Reddy's Laboratories received marketing authorization from Brazil's ANVISA for its generic semaglutide injection. The approval targets Brazil's diabetes market, estimated at approximately USD 244.6 million.

Regulatory ApprovalAlembic Pharmaceuticals Ltd APLLTDAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Alembic Pharmaceuticals Regulatory Approval

Alembic Pharmaceuticals received USFDA final approval for its generic Olopatadine Hydrochloride Ophthalmic Solution 0.7% ANDA. The product's US market is estimated at $20 million, per IQVIA.

Regulatory ApprovalEmmbi Industries Ltd EMMBIAlfa AlertAn Alfa Alert is ALFA Finder's top-priority alert: filings that can move a stock, such as orders, fund raises and approvals, sent to subscribers on Telegram within seconds of reaching the exchange.

Emmbi Industries Regulatory Approval

SEBI exempted the Makrand and Rinku Appalwar business trusts from SAST takeover rules for an internal family share transfer. Control and promoter shareholding remain unchanged.